InMed Pharmaceuticals Inc IN.TO :
* INMED PHARMACEUTICALS REPORTS FIRST QUARTER FISCAL 2020 FINANCIAL RESULTS AND PROVIDES RESEARCH AND DEVELOPMENT AND BUSINESS UPDATE
* INMED PHARMACEUTICALS- RECORDED A NET LOSS OF $3.89 MILLION, OR $0.02 PER SHARE IN QUARTER
* INMED PHARMACEUTICALS- AT SEPTEMBER 30, 2019, THE COMPANY'S CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS WERE $14.77 MILLION